Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corn silk aqueous extract is a water-based preparation derived from the silky fibers (stigmas) of the Zea mays L. (corn) plant. Traditionally used in Chinese and Native American medicine, it contains a variety of bioactive compounds including alkaloids, flavonoids, phenols, saponins, tannins, and phytosterols[3][4]. Research suggests that this extract may have antioxidant and anti-inflammatory properties as well as potential antihypertensive effects through inhibition of α-amylase and α-glucosidase enzymes[3]. It has also been studied for possible benefits in reducing blood sugar levels and blood pressure[1][2]. However, robust clinical evidence supporting these uses is lacking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corn silk aqueous extract.